Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy
- PMID: 24820942
- PMCID: PMC4143898
- DOI: 10.1097/YCT.0000000000000137
Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy
Abstract
For many patients with neuropsychiatric illnesses, standard psychiatric treatments with mono or combination pharmacotherapy, psychotherapy, and transcranial magnetic stimulation are ineffective. For these patients with treatment-resistant neuropsychiatric illnesses, a main therapeutic option is electroconvulsive therapy (ECT). Decades of research have found ECT to be highly effective; however, it can also result in adverse neurocognitive effects. Specifically, ECT results in disorientation after each session, anterograde amnesia for recently learned information, and retrograde amnesia for previously learned information. Unfortunately, the neurocognitive effects and underlying mechanisms of action of ECT remain poorly understood. The purpose of this paper was to synthesize the multiple moderating and mediating factors that are thought to underlie the neurocognitive effects of ECT into a coherent model. Such factors include demographic and neuropsychological characteristics, neuropsychiatric symptoms, ECT technical parameters, and ECT-associated neurophysiological changes. Future research is warranted to evaluate and test this model, so that these findings may support the development of more refined clinical seizure therapy delivery approaches and efficacious cognitive remediation strategies to improve the use of this important and widely used intervention tool for neuropsychiatric diseases.
Figures


References
-
- Rush AJ, et al. Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression. New England Journal of Medicine. 2006;354(12):1231–1242. - PubMed
-
- Sachs GS, et al. Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression. New England Journal of Medicine. 2007;356(17):1711–1722. - PubMed
-
- Lieberman JA, et al. Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia. New England Journal of Medicine. 2005;353(12):1209–1223. - PubMed
-
- Lisanby SH. Electroconvulsive Therapy for Depression. New England Journal of Medicine. 2007;357:1939–1945. - PubMed
-
- Weiner RD, et al. Electroconvulsive therapy device classification: Response to the FDA advisory panel hearing and recommendations. Journal of Clinical Psychiatry. 2013;74(1):38–42. - PubMed
Supplemental References
-
- Hickie I, et al. Prediction of ECT response: validation of a refined sign-based (CORE) system for defining melancholia. The British Journal of Psychiatry. 1996;169(1):68–74. - PubMed
-
- Petrides G, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT. 2001;17(4):244–53. - PubMed
-
- Nuechterlein KH, et al. Individual placement and support for individuals with recent-onset schizophrenia: integrating supported education and supported employment. Psychiatric Rehabilitation Journal. 2008;31(4):340–349. - PubMed
-
- Kurtz MM. Neurocognitive impairment across the lifespan in schizophrenia: an update. Schizophrenia Research. 2005;74(1):15–26. - PubMed